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Abstract: Recruitment of the matrix protein M1 to the assembly site of the influenza virus is
thought to be mediated by interactions with the cytoplasmic tail of hemagglutinin (HA). Based
on a comprehensive sequence comparison of all sequences present in the database, we analyzed
the effect of mutating conserved residues in the cytosol-facing part of the transmembrane region
and cytoplasmic tail of HA (A/WSN/33 (H1N1) strain) on virus replication and morphology of
virions. Removal of the two cytoplasmic acylation sites and substitution of a neighboring isoleucine
by glutamine prevented rescue of infectious virions. In contrast, a conservative exchange of the same
isoleucine, non-conservative exchanges of glycine and glutamine, deletion of the acylation site at the
end of the transmembrane region and shifting it into the tail did not affect virus morphology and had
only subtle effects on virus growth and on the incorporation of M1 and Ribo-Nucleoprotein Particles
(RNPs). Thus, assuming that essential amino acids are conserved between HA subtypes we suggest
that, besides the two cytoplasmic acylation sites (including adjacent hydrophobic residues), no other
amino acids in the cytoplasmic tail of HA are indispensable for virus assembly and budding.
Keywords: influenza virus; assembly; hemagglutinin; cytoplasmic tail; transmembrane region;
acylation; palmitoylation; M1; PACS; J0101
1. Introduction
Most models of influenza virus assembly postulate a direct interaction between the viral matrix
protein M1 and the cytoplasmic domains of the envelope glycoproteins hemagglutinin (HA) and/or
neuraminidase (NA) as a driving force for virus assembly [1–3]. However, such an interaction has
never been demonstrated biochemically, for example by co-precipitation approaches. Experiments to
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demonstrate that an interaction of HA and NA with M1 by indirect methods yielded contradictory
results. M1 is not intrinsically targeted to the assembly site, the apical plasma membrane, but
rather localizes to the cytosol, the nucleus and a significant fraction to internal membranes,
such as the Golgi [4]. In one report, co-expression of M1 with HA and NA did stimulate the
membrane association of the M1 protein significantly [5], but this effect was not seen in other
studies [6,7]. Subsequently, detergent extraction at low temperature was used to demonstrate
the specific interaction of M1 with HA and NA [8]. Both HA and NA fractionate into detergent
resistant membranes (DRMs), whereas M1 expressed alone was soluble, but became resistant when
co-expressed with HA and NA. In order to define the minimal number of elements required for virus
budding, it was found that HA, when expressed alone, was released as virus-like particles (VLPs) if
sialidase activity is provided. Co-expression of NA and M2 increased VLP production. Expression
of M1 alone does not produce VLPs, but M1 is incorporated into VLPs if HA is also expressed.
Furthermore, when the cytoplasmic tails (CT) were deleted from NA and especially from HA, tailless
glycoproteins were included in the VLPs, but M1 failed to be efficiently incorporated [9]. The data
are consistent with a model in which the glycoproteins control virus budding by sorting to lipid raft
nanodomains and recruiting the internal viral core components.
The most pronounced feature of the cytoplasmic tail of HA is the attachment of fatty acids to
(mostly) three conserved cysteine residues [10,11]. Although this modification is usually described
as palmitoylation, we found by mass spectrometry of HA from virus particles that two different
fatty acids are attached, palmitate (C 16:0) and stearate (C 18:0). Whereas palmitate is exclusively
attached to two cytoplasmic cysteine residues, stearate is bound only to a cysteine at the end
of the transmembrane domain (TMD) [12]. The hydrophobic modification of HA is essential for
virus replication, since (depending on the virus strain) either virus mutants with more than one
acylation site deleted show drastically impaired growth or could not be created at all by reverse
genetics [13–15]. Acylation facilitates raft-association of HA [16] and thus enrichment of the protein
in small nanodomains of the plasma membrane [17,18], an observation which might explain why
palmitoylation affects both assembly of virus particles and the membrane fusion activity of HA [19].
Given the central role of the cytoplasmic tail of HA for virus budding, it is surprising that
recombinant virus with tailless HA could be generated by reverse genetics [20]. The resulting
virus particles had the same morphology and protein composition as wild-type (wt) virus; only
the budding efficiency and infectivity of the virions were slightly reduced. A virus where the
cytoplasmic tails were deleted from both HA and NA exhibited more severe defects, especially
aberrant morphology and altered genome packaging [21]. The relatively mild phenotype for the
virus with tailless HA might be due to the specific constellation of viral genes in these experiments,
i.e., HA from the A/Udorn/72 (H3N2) (Udorn) strain in the background of the A/WSN/33 (H1N1)
(WSN) strain. It was subsequently shown that deletion of cytoplasmic acylation sites from HA of the
Udorn virus is lethal for virus replication, but recombinant virus could be rescued and grew to only
moderately depressed titers by expression of M1 from the WSN strain [13]. Thus, a defect in virus
assembly caused by a lack of acylation could be compensated by a different M1 protein. Although
the molecular basis for this effect is mysterious, it is clear that the cytoplasmic tail is important for
virus replication. However, it is not known whether (besides the acylation sites) other amino acids
of the tail also affect virus assembly and replication as one would assume if HA mediates specific
interactions with M1 to recruit it to the assembly site.
In order to characterize the molecular signal for site-specific attachment of stearate we recently
analyzed recombinant WSN viruses containing HA with various mutations in its cytoplasmic tail [22].
Exchange of conserved amino acids in the vicinity of an acylation site had a moderate effect on the
stearate content. In contrast, shifting the TMD cysteine to a cytoplasmic location virtually eliminated
attachment of stearate, indicating that the location of an acylation site relative to the transmembrane
span is the decisive factor for attachment of stearate. More importantly, in this context, is the
observation that none of the mutations reduced attachment of fatty acids to HA; each of the cysteine
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residues were stoichiometrically acylated. Thus, any possible effect of the point mutations on virus
replication is not due to reduced acylation of adjacent cysteine residues but an inherent property of
the respective amino acids. Therefore, we now analyzed the growth properties, protein and genome
composition of these viruses. In addition, we provide a comprehensive sequence comparison of the
linker region, transmembrane domain and cytoplasmic tail of all HAs present in the database and
report reversions of amino acids we observed during propagation of recombinant viruses.
2. Materials and Methods
2.1. Amino Acid Conservation Analysis
Influenza A virus HA amino acid sequences were extracted from the Influenza Research
Database in March 2014 [23], which contained 33,254 entries of H1 to H17 subtypes with full-length
HA sequences. After elimination of redundant sequences, the remaining 17,311 unique sequences
were aligned, while 11,543 and 5768 sequences were used for alignment of HAs belonging to group-1
and group-2, respectively. Alignment was done using the MAFFT program, which is based on
the FFT-NS2 algorithm [24,25]. To represent the sequence conservation graphically, the WebLogo 3
program was applied constructing amino acid sequence logos [26–28].
2.2. Cells
Madin-Darby canine kidney (MDCK II, ATCC CRL-2936) and human embryonic kidney (HEK)
293T (ATCC CRL-11268) cells were cultured in Dulbecco’s modified Eagle’s medium (DMEM;
PAN Biotech, Aidenbach, German) supplemented with 10% FBS (Perbio, Bonn, Germany) at 37 ˝C,
5% CO2 and 95% humidity, using standard techniques.
2.3. Generation of Recombinant Virus
Recombinant influenza A/WSN/33 (H1N1) virus was generated using an eight-plasmid reverse
genetics system [29], where each plasmid contains the cDNA of a single viral RNA segment,
flanked by suitable promoters. In the HA encoding cDNA segment, the codon for I563 (ATA) was
replaced by the isoleucine codon TTG, G557 (GGG) was replaced by the alanine codon GCT and
the glutamic acid codon GAA, respectively. Q560 (CAG) was replaced by the glutamine codon
GAA. G547 (GGG) was replaced by the serine codon ACG. C554 (TGT) and L559 (TTG) were
replaced by the serine codon (AGC) and the cysteine codon (TGC), respectively using QuickChange
mutagenesis (Stratagene, Waldbronn, Germany), and confirmed by sequencing (GATC Biotech,
Konstanz, Germany). For generation of acylation mutants the cysteine codon TGT (Cys) was changed
to AGC (Ser) resulting in Ac1, TGC (Cys) was replaced by TCT (Ser) and TGC (Cys) was changed to
AGT (Ser) generating Ac2 and Ac3, respectively.
HEK 293T cells in 60 mm dishes were transfected with the eight plasmids encoding WSN
cDNA (1 µg each) using TurboFect (Fermentas/Thermo Fisher Scientific, St. Leon-Rot,) in OptiMEM
medium (Invitrogen, Karlsruhe, Germany). At 4–6 h after transfection, the medium was replaced
by infection medium (DMEM containing 0.2 % bovine serum albumin (BSA), 0.1% foetal bovine
serum (FBS), 2 mM glutamine, 100 U/mL penicillin/streptomycin and 1 µg/mL TPCK-treated
trypsin, (Sigma-Aldrich, Taufkirchen, Germany) and incubation was continued at 37 ˝C. At 48 h
after transfection, the supernatants were harvested and cleared of debris by low-speed centrifugation
(2000ˆ g, 5 min, 4 ˝C). The supernatant was used to infect MDCK cells for virus propagation. After 1 h
of adsorption, the cells were washed with PBS, infection medium was supplied and incubation was
continued until a cytopathic effect became evident. The supernatant was then harvested.
2.4. Sequencing of HA from Virus Particles
To check for correctness of the HA sequences in the recombinant viruses, RNA was isolated
from cleared cell culture supernatants with Invisorb Spin Virus RNA Mini Kit (Stratec, Birkenfeld,
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Germany) followed by reverse-transcription and polymerase chain reaction (RT-PCR) using HA
specific primers and the OneStep RT-PCR kit (Qiagen, Hilden, Germany). Before sequencing, PCR
products were treated with the ExoSAP-IT Cleanup Kit (Affymetrix, Halbergmoos, Germany) to
remove excess of primers and desoxinucleotide triphosphates (dNTPs), which might hinder the
sequencing reaction. Two µL ExoSAP-IT reagent was added to 5 µL PCR product, and incubated
at 37 ˝C for 15 min and heat-inactivated for 15 min at 80 ˝C. Sequencing was performed by GATC
Biotech (Konstanz, Germany).
2.5. Plaque Assay
Plaque assays were performed on MDCK cells in 6-well plates according to standard procedures.
Briefly, cells were infected with serial tenfold dilutions of the virus supernatants in infection medium,
incubated for 1 h at 37 ˝C, washed with PBS and overlaid with 0.9% SeaKem LE agarose (Lonza,
Verviers, Belgium) in Eagle’s minimum essential medium (Lonza, Verviers, Belgium) supplemented
with 0.2% BSA, 0.1% FBS, 2 mM glutamine and TPCK-treated trypsin (1µg/mL). After 3 days of
incubation, the cells were stained using 0.02% neutral red (Biochrom, Berlin, Germany) in PBS and
the plaques were counted. Plaque sizes were calculated from digital images using Image J.
2.6. Hemagglutination Assay
HA tests were performed to quantify virus particles by hemagglutination. Freshly drawn
chicken blood was washed three times in sterile PBS (centrifugation for 5 min at 2000ˆ g), the
working solution was adjusted to 0.5%. Two-fold virus dilution series with a final volume of 50 µL
were prepared in 96-V-well microtiter plates. Then, 50 µL red blood cell solutions were added per
well, mixed and incubated for 30 min at 4 ˝C. The titer was determined by the last viable lattice
structure found.
2.7. Electron Microscopy
For negative staining, virus supernatants from infected MDCKII cells were harvested and cleared
of debris by low-speed centrifugation (2000ˆ g, 5 min, 4 ˝C). The plaque titer was determined and
aliquots containing approximately 107 PfU/mL were mixed with fixative (stock solution of 20%
paraformaldehyde (PFA; Roth, No. 0335.3, Karlsruhe, Germany) in 0.5 M HEPES buffer (pH 7.2),
which was heated to 60–70 ˝C for 20 min to shift the equilibrium towards non-polymerized FA)
to a final concentration of 2% formaldehyde and incubated for 1 h at room temperature before
storing at 4 ˝C. A drop (10 µL) of the test suspension was placed directly onto a glow-discharged
electron microscopy sample support (400 mesh copper grid, covered with a carbon reinforced plastic
film). After adsorption for 10 min at room temperature, the grids were washed three times in
double distilled water and negatively stained with 1% uranyl acetate. The grids were examined
using a JEM-2100 transmission electron microscope (JEOL Corp., Freising, Germany) operated at
200 KV. Micrographs were recorded with a Veleta CCD camera (Olympus Soft Imaging Solutions)
at a resolution of 2048 ˆ 2048 pixels.
2.8. Growth Kinetics of Recombinant Virus
To assess growth kinetics, MDCK cells were infected with recombinant WSN at a low m.o.i.
(0.01 or 0.001). After 1 h of adsorption and washing with PBS, infection medium (DMEM containing
0.2% bovine serum albumin, 0.1% FBS, 2 mM glutamine, 100 U/mL penicillin/streptomycin and
1 µg/mL TPCK-treated trypsin, Sigma-Aldrich) was added. Aliquots were removed from cell culture
supernatant after a defined incubation time, cleared of debris and stored at ´80 ˝C before titer
determination by plaque assay.
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2.9. Virus Preparation, SDS-PAGE, Western Blotting and Radioactive Labeling
Virus particles were produced by infecting MDCK cells in a 15 cm dish at an m.o.i. of >2. At 24 h
after infection, the supernatants were harvested, cell debris was removed (2000ˆ g, 10 min, 4 ˝C), and
the virus was pelleted from the supernatant by ultracentrifugation (Beckman SW-28 rotor, Krefeld,
Germany, 28,000 r.p.m., 2 h, 4 ˝C), resuspended in 100 mL PBS and analyzed by sodium dodecyl
sulfate polyacrylamide gel electrophoresis (SDS-PAGE) under non-reducing conditions followed by
Western blotting using a polyclonal antiserum against fowl plague virus, which cross-reacts with
WSN M1, and horseradish peroxidase (HRP)-coupled secondary antibodies for chemiluminescence
detection using ECL Plus substrate (GE Healthcare, Solingen, Germany) and a Fusion SL camera
system (Promega, Mannheim, Germany), which detects photons over a wide linear signal-response
range. In order to prepare radioactive labelled virus particles the cell culture medium was replaced at
3 h post infectionem (p.i.) by DMEM lacking methionine, cysteine and glutamine, supplemented with
0.2% BSA, 0.1% FBS, 5 mM glutamine, 1 µg/mL TPCK-treated trypsin and 0.3 mCi/mL (11.1 kBq)
[35S]-methionine/cysteine (EasyTag™ EXPRE35S35S Protein Labelling Mix; PerkinElmer, Rodgau,
Germany). Virus preparations were subjected to SDS-PAGE under non-reducing conditions and
fluorography using 1 M salicylate. The dried gel was exposed to X-ray film and bands intensities
were analyzed with Bio-1 D software (PeqLab, Erlangen, Germay).
2.10. Quantitative Real-Time RT-PCR
In order to analyze an equivalent number of virions the supernatants from infected MDCK cells
were adjusted to an HA titer of 26. RNA was then extracted with the Invisorb Spin Virus RNA
Mini Kit (Stratec) and cDNA synthesized with the Maxima H Minus First Strand cDNA Synthesis
Kit (Thermo Scientific, Braunschweig, Germany). 4 µL 5ˆ RT-Buffer, 1µL dNTPs (10 mM), 1 µL
Oligo(dT)18 Primer (100 µM), 1 µL Maxima H Minus Enzyme mix and 13 µL RNA were used per
sample, which were incubated at 50 ˝C for 30 min. The reaction was terminated by incubation for
5 min at 85 ˝C.
The reaction product was directly used in a quantitative RT-PCR with the following primers
specific for the influenza A virus M gene segment: Forward primer (51Ñ31): AGATGAGTCTTCT
AACCGAGGTCG, reverse primer (51Ñ31): TGCAAAAACATCTTCAAGTCTCTG (Invitrogen).
Real-time RT-PCR was performed utilizing a TaqMan probe, OneTaq DNA polymerase (NEB) and
the ICYCLER-IQ5 Multicolor Real Time PCR Detection System (BIO-RAD, München, Germany).
One assay with a total volume of 25 µL contained 5 µL 5ˆ OneTaq-buffer, 16 µl RNAase free
water, 0.5 µL dNTPs (100 µM), 0.25µL forward and reverse primer (100 µM), 0.75 µL probe (10µM,
6FAM-TCAGGCCCCCTCAAAGCCGA-TMR), 0.25 µL OneTaq DNA polymerase and 2 µL cDNA as
template. Temperature profile: 3 min, 95 ˝C (1ˆ); (10 s, 95 ˝C; 30 s, 55 ˝C (annealing and elongation))
(40ˆ). Fluorescence values (FAM) were collected during the annealing step. A standard curve was
generated by using serial dilutions of an in vitro transcribed, M segment-derived RNA transcript.
3. Results
3.1. Sequence Comparison of the Linker Region, Transmembrane Domain and Cytoplasmic Tail between
HA Subtypes
Whereas the crystal structure of the ectodomains of various HA subtypes has been determined,
very little is known about the remaining part of the molecule, the cytoplasmic tail, the transmembrane
domain (TMD) and the linker region that connects the TMD to the ectodomain. Based on the amino
acid sequence as well as on the 3D structures of their ectodomains the 18 antigenic subtypes of HA
are divided into two evolutionary groupings: group-1 (H1-group; H1, H2, H5, H6, H8, H9, H11,
H12, H13, H16, H17, H18) and group-2 (H3-group; H3, H4, H7, H10, H14, H15) [30,31]. To identify
conserved residues, we have extracted every full length HA sequence from the influenza A virus
database, deleted the redundant ones and aligned the unique sequences of the linker, TMD and CT
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region, either together or separated into group-1 and group-2 sequences. The frequency of individual
amino acids at each position is listed in Table S1 for above mentioned HA subtypes. To make the
wealth of data more comprehensible, they were visualized with the WebLogo 3 program. Results are
displayed as logos in Figure 1, either all sequences together or separately for group-1 and group-2
subtypes. Each logo consists of stacks of amino acid symbols, one stack for each position in the
sequence. The overall height of each stack indicates the sequence conservation, while the height of
each symbol within the stack indicates the relative frequency of the respective amino acid at that
position. Thus, the diagram displays the consensus amino acid sequence (top letters at each position
of the logo) as well as the amino acid frequencies and the total sequence conservation. Groups of
amino acids with similar biochemical properties are displayed by different colors. Negatively or
positively charged residues are in red and blue, respectively, large and hydrophilic residues are in
purple, neutral amino acids are in green and hydrophobic residues are in black. Note, however, that
analysis by alignment of all sequences is biased, since sequences from H1 (~6400), H3 (~4300) and H5
(~2600) subtype are overrepresented in the Flu database, whereas significantly fewer sequences are
available for the other subtypes. Therefore, the consensus sequence of each hemagglutinin subtype is
displayed in Table S2.
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B4URE7) in the upper and middle panel and to the HA from A/Udorn/72 (H3N2) (UniProt Acc. 
Q20MD6) in the lower panel. The relative borders of the linker region, transmembrane domain 
(TMD) and cytoplasmic tail (CT) are indicated. The residues mutated in HA from WSN are marked 
with orange rectangles above the group-1 logos. 
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in the database was used for the alignment represented by the WebLogo 3.3 server, either all subtypes
together (upper panel) or group-1 (middle panel) and group-2 (lower panel) sequences separately.
The overall height of the stack indicates the sequence conservation at that position, while the height
of symbols within the stack indicates the relative frequency of each amino acid at that position. Gaps
found in all HA subtypes (except small samplings of H11, H13, H16 sequences) and in all group-1
subtypes (compared to the group-2 ones) are marked with one or two asterisks, respectively. Amino
acid numeration correspond to the HA from A/WSN/33 (H1N1) (UniProt Acc. B4URE7) in the upper
and middle panel and to the HA from A/Udorn/72 (H3N2) (UniProt Acc. Q20MD6) in the lower
panel. The relative borders of the linker region, transmembrane domain (TMD) and cytoplasmic tail
(CT) are indicated. The residu s mutated in HA from WSN are marked with orange rectangles above
the group-1 logos.
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As obvious from Figure 1, the linker region, TMD and cytoplasmic tail differ both by their
sequence conservation and types of amino acid residues present. The linker region is the most
variable among the three domains, both by its length (10–14 amino acids depending on the HA
subtype) and the type of amino acids; positively and negatively charged, polar and hydrophobic
residues are abundant. This region is likely to be flexible since it contains the cleavage sites of
proteases that were used to enzymatically remove HA’s ectodomain [32,33]. The variable part of the
linker region is encompassed by conserved residues. A valine and a leucine located at the beginning
and a tyrosine at the end of the linker region are conserved trough all HA subtypes while several
other residues are conserved only in group-1 (K520) or group-2 subtypes (526GYKD529). Amino acid
numeration through all the text is for the WSN (H1) and Udorn (H3) HA, respectively.
The transmembrane region contains 26–27 amino acid residues and is (by definition) demarcated
on both sides by either charged (K, D, E) or large and hydrophilic residues (N or Q). Its N-terminal
part that contacts the outer half of the lipid bilayer is highly conserved, both between all subtypes
and more pronounced within group-1 and group-2 HAs. The mean conservation value (the relative
height of logo stacks) of the N-terminal conserved cluster is ~93% for group-1 (amino acid positions
529–542) and group-2 HAs (531–543). The high conservation of amino acids suggests that this region
is not only a membrane anchor (that, in principle, could accommodate many different hydrophobic
amino acids) but might play a further, more specific role, for example binding to hydrophobic
ligands. In accordance, we have recently identified a cholesterol-consensus motif in group-2 HAs
that comprises the completely conserved residues Tyr 527 and Lys 528 in the linker region and Leu
532 and Trp 533 at the beginning of the TMD [34]. In contrast, the C-terminal half of the TMD exhibits
much more amino acid variation, a mean conservation value of only 60% for amino acids 543–550
in both group-1 and group-2 HAs was calculated. Up to five different amino acids, sometimes
non-conservative substitutions are present at some positions. However, all amino acids are common
components of transmembrane regions, and charged residues do not occur.
The cytoplasmic tail (10–11 amino acids) is again highly conserved. Noteworthy, five residues
Gly 557, Cys 561, Ile 563, Cys 564 and Ile 565 (WSN numbering) are almost invariant, not only within
one group but also through all HA subtypes and are therefore likely to be of functional importance.
Ile 563, the palmitoylated C564 and I565 form a hydrophobic patch at the C-terminal end of the tail
that is also conserved in HA of Influenza B virus (Table S2). C561 located in close proximity is the
second palmitoylated residue in the tail. A completely conserved glycine, an amino acid lacking
a side chain, but having a substantial effect on the secondary structure of polypeptides, is present at
position 557 in the middle of the cytoplasmic tail. Other residues are not conserved between all HA
subtypes but almost invariant within one group. The residue preceding the second acylation site has
an amino group in its side chain, which might interact with M1. It is always an arginine in group-2
and either a glutamine or an arginine in group-1 HAs. The beginning of the cytoplasmic tail is defined
by hydrophilic residues. In group-1, it is just one residue, a conserved asparagine and in group-2 two
hydrophilic amino acids are present, glutamine or lysine followed by lysine, asparagine or arginine.
The location of the third acylation site is also not completely conserved. However, as is obvious
from their consensus sequences, each HA subtype has at least three cysteine residues (Table S2).
In most HA subtypes, it is located at the cytosol-facing end of the TMD, at position 554 in group-1
or at position 555 in group-2 HAs. If a cysteine is not present at the end of the TMD, such as in H8
and H9 subtype HAs, a third cysteine is present in the cytoplasmic tail at position 559. Furthermore,
H11, H13 and H16 subtypes also have a cysteine at that position but not at position 561. Finally,
H11-subtype HAs have even four cysteines, one at the end of the TMD and three in the cytoplasmic
tail. We have previously shown that all these cysteines of each HA subtype are stoichiometrically
acylated, the ones in the tail exclusively with palmitate, the cysteine at the end of the TMD with
(depending on the virus strain and host cell) 30% to 100% stearate [22,35]. Interestingly, if an HA
subtype does not have a cysteine at one of the four positions, it is replaced by a hydrophobic amino
acid, either by methionine, valine, leucine, isoleucine or phenylalanine suggesting that these positions
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have the propensity to interact with membranes. Another peculiar feature not immediately obvious
from the alignment of sequences is the presence of (at least) one glycine in the variable region of the
TMD of almost all (except H4) HA subtypes (Table S2). Glycines are usually not compatible with the
α-helical secondary structure, and the transmembrane region likely adopts and thus might change
their orientation with respect to the lipid membrane border.
3.2. Mutation of Cytoplasmic Palmitoylation Sites and Non-Conservative Substitution of C-Terminal
Isoleucine Prevent Virus Rescue
Based on the described sequence conservation, we created a set of mutants to investigate which
amino acids in the cytoplasmic tail of HA are required for or affect virus replication (Table 1).
The whole cytoplasmic tail was deleted by replacement of glycine 557 with a stop codon (mutant
G557 stop). The same absolutely conserved glycine was also exchanged by the small amino acid
alanine (G557A) and by a large, negatively charged glutamic acid residue (G557E). The three cysteine
residues at positions 554, 561 and 564 representing the conserved acylation sites were mutated to
serine (mutants Ac1, Ac2 and Ac3, respectively). Ac1 was further mutated to introduce a cysteine
as putative acylation site instead of leucine at position 559 (mutant Ac1 + L559C). The resulting
mutant thus contains an identical location of the three cysteines as in H8 and H9 subtype HAs from
naturally occurring avian, equine, swine, and human virus strains. The first of the two isoleucines
encompassing the last acylation site at the C-terminus of HA was exchanged by either the similar
amino acid leucine (I563L) or by the large, but hydrophilic residue glutamine (I563Q). Furthermore,
position 560, which is mainly glutamine in group-1 subtypes (including HA of WSN) and always
arginine in group-2 subtypes, was converted to glutamic acids (mutant Q560E). Finally, a glycine
present in the TMD of each HA subtype but at a slightly different position (Table S2) was mutated to
an isoleucine, a hydrophobic amino acid usually compatible with transmembrane regions of proteins.
However, since the codon for isoleucine always reverted to a codon specifying a serine (see below)
the mutant is termed G547S. For each mutant, we changed at least two nucleotides at the respective
codon to prevent reversion to the wild-type sequence.
Table 1. Mutations introduced in the transmembrane region and cytoplasmic tail of hemagglutinin
(HA). Amino acid sequence of the transmembrane region and cytoplasmic tail of HA from the
A/WSN/33 (H1N1) strain. Acylated cysteine residues are highlighted in grey, introduced amino
acid exchanges are in bold. An asterisk indicates a stop codon. + or ´ indicates whether infectious
virus could be rescued by transfection of cells.
Mutants Transmembrane Cytoplasmic Tail Virus
Wild type LGAISFWM C S NGSLQ C RI C I +
G557Stop LGAISFWM C S N * ´
Ac2 (C561S) LGAISFWM C S NGSLQSRI C I * ´
I563Q LGAISFWM C S NGSLQ C RQ C I * ´
Ac3 (C564S) LGAISFWM C S NGSLQ C RISI * ´
G547S LSAISFWM C S NGSLQ C RI C I * +
Ac1 (C554S) LGAISFWMSS NGSLQ C RI C I * +
Ac1+L559C LGAISFWMSS NGSCQ C RI C I * +
G557A LGAISFWM C S NASLQ C RI C I * +
G557E LGAISFWM C S NESLQ C RI C I * +
Q560E LGAISFWM C S NGSLE C RI C I * +
I563L LGAISFWM C S NGSLQ C RL C I * +
Having verified the mutation by sequencing, the mutant HA plasmid together with seven
plasmids encoding the other viral proteins were transfected into HEK 293T cells and three days later
the supernatant was tested for virus particle release by a plaque assay in MDCK cells. For four
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mutants, HA with deleted cytoplasmic tail (G557stop), HA with deleted C-terminal palmitoylation
sites (Ac2, Ac3) and the mutant with a non-conservative substitution in the C-terminal hydrophobic
patch (I563Q), we never (five transfections) rescued infectious virus particles, although control
experiments using plasmids with wild-type HA done in parallel showed that transfection was
successful. Note that the failure to generate infectious virus particles with HA G557 stop and HA
I563Q is not due to a complete blockade of acylation since these HA mutants are efficiently labeled
with 3H-palmitate when they are expressed from a plasmid in CV1 cells [22].
In summary, both palmitoylation sites in the cytoplasmic tail, but not the stearoylated cysteine
at the end of the TMD of H1 subtype HA are indispensable for virus replication.
3.3. Reversion at Three Codons Causing Amino Acid Exchanges during Amplification of Recombinant Virus
The other mutations in HA did not prevent rescue of infectious virus, which was amplified
for further characterization. After each amplification step, RNA was extracted from virus particles,
cDNA was prepared and ~300 nucleotides at the 51 end of the HA gene were sequenced to ensure
that the mutation is still present. During subsequent passage of recombinant virus in MDCK cells, we
observed nucleotide reversions at three of the mutated codons. For the mutant having a substitution
in the TMD (G547I), we always (five attempts) observed a single nucleotide exchange from ATT
(isoleucine) to AGT (serine). A partial exchange of T to G, reflected by superimposed peaks for the
respective bases, was already visible in the viral genomes prepared from the transfection supernatant
and the resulting virus G547S completely outgrew G547I after two amplifications (Figure 2, upper
row) strongly indicating that it has a competitive fitness advantage. For the mutant with the shifted
acylation site (Ac1 + L559C), we observed three times in five experiments that the codon AGC (serine
554) changed to ATC (isoleucine), which outgrew the virus with the desired mutation (Figure 2,
middle row). Other amino acid substitutions, which would be possible by a single nucleotide
exchange at that codon, i.e. to arginine, asparagine, threonine, glycine and surprisingly also to
cysteine (specified by another codon (TGC) than the one in wild type HA (TGT)), were never
observed. We can only speculate why a reversion to cysteine did not occur but this region in the viral
genome is part of a larger signal for packaging of Ribo-Nucleoprotein Particles (RNPs) into budding
virus particles [36]. One might conclude that certain nucleotides compromise packaging of the HA
encoding segment such that the resulting virus particles are not infectious. The repeated reversion
from serine to isoleucine suggests that a long and hydrophobic amino acid at the end of the TMD
confers a growth advantage if an acylated cysteine is not present.
Finally, one time in five experiments we observed that in the mutant G557E the codon GAA
reverted to GGA. This led to a mutation to glycine, the amino acid present in the wild type HA where
it is specified by a different codon. Although substitution of that completely conserved glycine has no
drastic effect on virus growth (see below), it apparently confers a fitness advantage since the revertant
virus completely outgrew the mutant one in just two amplification steps (Figure 2, lower row).
However, for the last two revertants, we were able to obtain viruses with the desired mutation
that were further characterized. The other four recombinant viruses were stable for at least three
passages, reversions at the mutated codon or at other sites in the C-terminal ~100 amino acids of HA
were never observed.
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Figure 2. Observed reversions in codons of the mutants G547I, Ac1 + L559C and G557E. (A) 
Sequencing chromatograms of plasmids after site-specific mutagenesis and before transfection into 
293T cells; (B) Sequencing chromatograms obtained from virus particles three days after transfection 
of 293T cells; (C) Sequencing chromatograms obtained from virus particles propagated at an m.o.i. 
of 0.1 one day after infection of MDCK cells; (D) DNA sequence after a second propagation of the 
virus in MDCK cells. After 24 h the supernatants were collected, the viral RNA was isolated and 
subjected to RT-PCR and sequencing. Sequence of the mutated codon, the specified amino acid as 
well as the respective information for wild type HA is indicated. The reversion of G547I to G547S 
was always observed (five attempts). Thus, we were not able to obtain stable virus particles with an 
isoleucine at position 547. Reversion of C554S (Ac1) + L559C to C554I + L559C occurred three times 
and of G557E to G557G once in five experiments. 
3.4. Growth Kinetics of Recombinant Viruses 
To analyze the replication kinetics of the viruses, MDCK cells were infected with wild type 
WSN or one of the mutants at a low multiplicity of infection (m.o.i.), and the supernatants were 
collected at various times and assessed for virus titer by plaque assay. Overall, differences in 
growth properties between wild type and mutant virus were rather subtle as seen in the growth 
curves calculated from three independent infections (Figure 3A–C). For the mutant with the deleted 
acylation site located at the end of TMD, titers were reduced by ~one log at each time point and 
accordingly Ac1 produced smaller plaques (Figure 3D). This is in perfect agreement with results 
previously published for the same mutant of H7 subtype HA and also with HA from WSN virus 
generated with a less efficient reverse genetics system [14,15]. Titers of the mutants with exchanged 
glycine residues in the TMD (G547S), or in the cytoplasmic tail (G557A and G557E) were reduced at 
most time points, but the titer difference to wild type did not exceed ~ 1.5 logs. Calculating the 
plaque forming unit (PFU) to HA titer ratio revealed that the relative infectivity of the mutants was 
reduced to 0.8 (G547S), 0.7 (G557A), 0.2 (AC1) and 0.01 (G557E) relative to wild type virus (1.0). The 
other mutants showed (almost) identical titers to wild type virus, no reduction in specific infectivity 
(I563L and Q560E = 1.8); and no difference in plaque size was obvious between these mutants and 
wild type WSN. 
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into 293T cells; (B) Sequencing chro atograms obtained from virus particles three days after
transfection of 293T cells; (C) Sequencing chromatograms obtained from virus particles propagated at
an m.o.i. of 0.1 one day after infection of MDCK cells; (D) DNA sequence after a second propagation
of the virus in MDCK cells. After 24 h the supernatants were collected, the viral RNA was isolated
and subjected to RT-PCR and sequencing. Sequence of the mutated codon, the specified amino acid
as well as the respective information for wild type HA is indicated. The reversion of G547I to G547S
was always observed (five attempts). Thus, we were not able to obtain stable virus particles with
an isoleucine at position 547. Reversion of C554S (Ac1) + L559C to C554I + L559C occurred three
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(G547S), or in the cytoplasmic tail (G557A and G557E) were reduced at most time points, but the
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Figure 3. Growth kinetics of recombinant influenza viruses with mutations in HA. (A–C) MDCK 
cells were infected with the indicated virus at an m.o.i. of 0.001 (A) or m.o.i. of 0.01 (B,C). Aliquots 
were removed from the supernatant at 16, 24, 48 and 72 h p.i. and titers were determined by plaque 
assay. Experiments were carried out in triplicate and are displayed as means ± standard error. Note 
that due to the inherent variability of growth experiments titers of wild type (WT) virus somewhat 
varied between experiments. To account for this variability we always included wild type virus in 
growth experiments, i.e., all the growth curves shown in one graph were done in parallel. (D) 
Plaque assays of wild type WSN and WSN carrying the indicated HA mutations. Plaque assays of 
each row were performed in parallel, i.e., with sister cultures infected and stained at the same time. 
Diameters of 20–40 plaques were measured using ImageJ and normalized to wild-type virus, which 
was analyzed in parallel. A student’s t-test was performed to determine a statistical significant 
difference between (relative) plaque diameters, However, only the mutant Ac1 produced 
consistently smaller plaques indicated by the asterisk (p < 0.05).  
Since the cytoplasmic tail of HA is supposed to recruit M1 to the budding site, we determined 
the proportion of both proteins incorporated into virus particles. In order to do so, we adjusted 
culture supernatants from virus infected MDCK cells to a HA titer of 26 and subjected aliquots to 
SDS-PAGE and Western blotting with polyclonal antiserum against fowl plague virus, which cross-
reacts with WSN M1 (Figure 4A). Quantification of M1 bands by chemiluminescence imaging from 
three different virus infections revealed that the amount of M1 is increased relative to HA in the 
mutants Ac1 and G557E and decreased in I563L and Q560E, but the calculated means are not 
statistically significant different from wild type. The large error bars of the standard deviation 
suggest that there is a rather large variance between virus preparations (Figure 4B). 
Figure 3. Growth kinetics of recombinant influenza viruses with mutations in HA. (A–C) MDCK cells
were infected with the indicated virus at an m.o.i. of 0.001 (A) or m.o.i. of 0.01 (B,C). Aliquots were
removed from the supernatant at 16, 24, 48 and 72 h p.i. and titers were determined by plaque assay.
Experiments were carried out in triplicate and are displayed as means ˘ standard error. Note that
due to the inherent variability of growth experiments titers of wild type (WT) virus somewhat varied
between experiments. To account for this variability we always included wild type virus in growth
experiments, i.e., all the growth curves shown in one graph were done in parallel. (D) Plaque assays
of wild type WSN an WSN carryi g the indicated HA mutations. Plaque assays of each row were
performed in parallel, i.e., with sist r cultures infected and stain d at the same time. Diameters of
20–40 plaques were measured using Imag J and nor lized to wild-typ virus, which was analyzed
in parallel. A student’s t-test was p rformed to determine a statistical signific nt difference betwee
(relative) plaque diameters, However, only th mutant Ac1 p oduced consistently smaller plaqu s
indicated b the asterisk (p < 0.05).
Since the cytoplasmic tail of HA is supposed to recruit M1 to the budding site, we determined the
proportion of both proteins incorporated into virus particles. In order to do so, we adjusted culture
supernatants from virus infected MDCK cells to a HA titer of 26 and subjected aliquots to SDS-PAGE
and Western blotting with polyclonal antiserum against fowl plague virus, which cross-reacts with
WSN M1 (Figure 4A). Quantification of M1 bands by chemiluminescence imaging from three different
virus infections revealed that the amount of M1 is increased relative to HA in the mutants Ac1 and
G557E and decreased in I563L and Q560E, but the calculated means are not statistically significant
different from wild type. The large error bars of the standard deviation suggest that there is a rather
large variance between virus preparations (Figure 4B).
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Figure 4. M1 and RNP content of recombinant virus particles with mutations in HA. MDCK cells 
were infected with an m.o.i. of four. After 24 h, the cell culture supernatant was harvested and 
adjusted to a HA titer of 26. (A) Aliquots were subjected to SDS-PAGE and Western blotting to 
detect M1. Solid lines between lanes separate different blots, whereas samples separated by dashed 
line were run on the same gel, but irrelevant lanes were removed; (B) M1 bands were quantified by 
chemiluminescence, normalized to wild type and results from three virus infections are displayed as 
mean ± SD. A Student s´ t-test (unpaired, two-tailed) revealed no significant difference in the HA/M1 
ratio between wild type and mutant virus particles; (C) Protein composition of virus particles 
metabolically labelled with [35S]-methionine. Band intensities from this film were quantified by 
densitometry and revealed the following results for the relative abundance of viral proteins: WT: 
HA 32%, NP 34%, M1 34%; Ac1: HA 27%, NP 43%, M1 30%; I563L: HA 20%, NP 20%, M1 60%; 
Q560E: HA 35%, NP 31%, M1 34%; G557A: HA 32%, NP 39%, M1 29%; G547S: HA 40%, NP 40 %, 
M1 20%; Ac1 + L559C: HA 32%, NP 41%, M1 27%; G557E: HA 32%, NP 39%, M1 29%; (D) Real-time 
PCR with M1 specific primers. The mean Ct value ± SD is shown for wild type and each mutant and 
was determined from three independent virus infections. A Student s´ t-test (unpaired, two-tailed) 
revealed a significant difference in the HA/RNP ratio between wild type and mutant virus particles 
only for the mutant I563L, which is indicated by an asterisk (p < 0.05). 
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adjusted to a HA titer of 26. (A) liquots were subjected to SDS-PAGE and Western blotting to detect
M1. Solid lines between lanes separate different blots, whereas samples separated by dashed line
were run on the same gel, but irrelevant lanes were removed; (B) 1 bands ere quantified by
chemiluminescence, normalized to ild type and results from three virus infections are displayed
as mean ˘ SD. A Student’s t-test (unpaired, two-tailed) revealed no significant difference in the
HA/M1 ratio between wild type and mutant virus particles; (C) Protein composition of virus particles
metabolically labelled with [35S]-methionine. Band intensities from this film were quantified by
densitometry and revealed the following results for the relative abundance of viral proteins: WT:
HA 32%, NP 34%, M1 34%; Ac1: HA 27%, NP 43%, M1 30%; I563L: HA 20%, NP 20%, M1 60%;
Q560E: HA 35%, NP 31%, M1 34%; G557A: HA 32%, NP 39%, M1 29%; G547S: HA 40%, NP 40 %,
M1 20%; Ac1 + L559C: HA 32%, NP 41%, M1 27%; G557E: HA 32%, NP 39%, M1 29%; (D) Real-time
PCR with M1 specific primers. The mean Ct value ˘ SD is shown for wild type and each mutant and
was determined from three independent virus infections. A Student’s t-test (unpaired, two-tailed)
revealed a significant difference in the HA/RNP ratio between wild type and mutant virus particles
only for the mutant I563L, which is indicated by an asterisk (p < 0.05).
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In order to estimate the relative amount of proteins incorporated into virus particles we
metabolically labelled virus infected cells with [35S]-methionine, prepared virions from cell culture
supernatants and subjected them to SDS-PAGE and fluorography. The resulting X-ray film and
quantification of bands showed that the main proteins of virus particles, HA, NP and M1 are present
in (roughly) equal proportions in the virus preparation from wild type virus and from the mutants
Q560E, G557E and Ac1 + L559C. The mutants G557A and I563L contain more M1 (~60%) at the
expense of both HA and NP whereas M1 is reduced (~20%) and both HA and NP are increased
in G547S. In contrast, Ac1 contains more NP (43%) and less M1 and HA. Although the effects seem
to be large for some mutants we want to express our skepticism about the reliability of the data since
even for wild type virus the relative ratios of HA, NP and M1 varied between different preparations
(HA: 25%–35%; NP: 35%–45%, M1: 30%–42%, data not shown, see also discussion).
Finally, to quantify the amount of RNPs (and hence of the viral genome) present in virus
particles, we performed quantitative real time PCR with M1 specific primers on virus samples
adjusted to a HA titer of 26 (Figure 4C). The results from three different virus preparations revealed
that two mutants have the same (G547S, Q560E) or a slightly higher cycle threshold (Ct) value
(28.2–28.6) compared to wild type WSN (27.5). However, a statistically significant difference was
obtained only for the mutant I563L that has a Ct value of 29.1. One cycle difference in the Ct value
indicates a two-fold difference in the amount of DNA suggesting that the content of RNPs in mutant
I563L is reduced to ~30% compared to wild type.
4. Discussion
In summary, we have shown here that the cytoplasmic tail of H1 subtype HA is essential for
virus replication since WSN virus with tailless HA could not be generated. This is in contrast to
a previous study, where viruses containing tailless HA from the Udorn strain (H3 subtype HA) could
be rescued in the background of a WSN helper virus and even revealed only little growth defects [20].
Except for the two cytoplasmic acylation sites, the C-terminal isoleucine residues and the glycine, the
tail sequences of HA from Udorn (KGNIRCNICI, stop codon was introduced instead of the K) and
from WSN (NGSLQCRICI, stop codon was introduced instead of the G) are different which might
explain the different results. In addition, it might be possible that M1 (or any other protein) that was
provided from WSN might allow rescue of otherwise non-infectious particles, as described for HA
from Udorn having deletions of acylation sites [13].
Individual amino acids in the tail of HA from WSN had very different effects on virus growth.
Deletion of the two cytoplasmic palmitoylation sites and non-conservative substitution of the adjacent
isoleucine by glutamine completely prevented rescue of infectious virus (Table 1). This is in
agreement with earlier studies using a less efficient reverse genetics system where rescue of infectious
WSN virus was not possible if Cys 560 or Cys 563 were mutated to serine. However, virus particles
could be generated if Cys 560 was exchanged by hydrophobic amino acids, such as alanine and
especially with tyrosine and phenylalanine [15]. Also in accordance with our findings are published
results using reverse genetics with two other influenza virus strains. Recombinant Udorn (H3 subtype
HA) and fowl plague virus (H7 subtype HA) where HA´s two cytoplasmic acylation sites were
substituted by serines could be generated, but the resulting virus particles were greatly growth
compromised [13,14]. Likewise, although the cytoplasmic tail of HA (including two palmitoylated
cysteine residues) from Influenza B virus is not absolutely required for virus replication, the resulting
virus revealed defects in replication [37].
In contrast, recombinant viruses with mutations in other conserved amino acids showed no
altered morphology of virus particles (Figure 5), some only subtle defects in growth kinetics
(Figure 3) and M1 and RNP content compared to wild type virus (Figure 4). The standard
methods we used, such as HA-assays and metabolic labeling experiments or Western-blotting, are
at best semi-quantitative and have an intrinsic error margin which probably exceeds possible small
differences between wild type and mutant viruses. Thus, more precise methods, such as quantitative
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mass spectrometry are required to reliably demonstrate differences in the protein composition of
wild type and mutant virus particles [38]. The pleomorphic morphology of Influenza virus particles
is a further obstacle that prevents rapid progress in the field. Assuming that every (infectious)
particle has eight different RNP segments, the number of NP molecules (and also PA, PB1, PB2) is
the same in each virion. However, since the membrane’s surface area varies between particles having
a different morphology the number of membrane proteins (and thus the ratio of internal to external
viral proteins) most likely varies between individual virions. In addition, at least 90% of particles
present in a virus preparation are not infectious, but a shift in the ratio of infectious to non-infectious
particles is only insufficiently described by calculating the PFU to HA titer ratio. Thus, new and more
precise methods need to be developed to understand the complex interplay between viral proteins
that leads to virus assembly and bud formation.
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Figure 5. Characterisation of WSN wild type and mutants by negative staining transmission electron 
microscopy. Representative negative stain images of the indicated virus particles harvested from the 
supernatant of infected MDCK cells. Scale bars = 200 nm. Differences in particle appearance are not 
due to morphological changes but to slight modifications of microscope settings and staining 
conditions of the virus suspensions. Occasionally, filamentous and aberrant formed particles were 
also observed in each virus preparation, the latter might be an artefact of ultracentrifugation [39]. 
However, although all effects are rather small (compared to the essential nature of the 
cytoplasmic palmitoylation sites and adjacent hydrophobic residues), the repeated occurrence of 
amino acid reversion suggests that conserved residues in the tail and in the TMD confer a growth 
advantage (Figure 2). The most striking example is the repeated and rapid occurrence of an amino 
acid reversion to serine if a conserved glycine in the TMD was exchanged to isoleucine, a typical 
constituent of transmembrane domains. Since the other possible single nucleotide exchanges in that 
codon would specify either a hydrophilic residue (asparagine) or hydrophobic amino acid 
(isoleucine, leucine, phenylalanine, valine, threonine, methionine), the latter are typical constituents 
of transmembrane regions, the repeated reversion to serine strongly suggests that a small amino 
acid is preferred at that position. The transmembrane region of HA is likely to be α-helical [40] and 
when the inner part of the TMD (541VLVVSLGAISFWMC554) is plotted as a helical wheel, G547 is 
located together with other small amino acids (V543, S550) on the same side of the helix as the 
stearoylated cysteine 554. One might speculate that these small residues are located on the outer 
surface of the trimeric TMD where they might form a groove which binds stearate to align it with 
the TMD helix as previously speculated [41]. Alternatively, glycine residues are often located at the 
interface between oligomeric transmembrane regions where they mediate helix-helix interactions 
[42]. In both cases the substitution of the small glycine residue (amino acid volume of 70 Å 3) by the 
large residue isoleucine (volume of 170 Å 3) might disrupt the assumed interaction and, therefore, a 
spontaneous reversion to serine (volume of 100 Å 3) confers a growth advantage. 
Figure 5. Characterisation of WSN wild type and mutants by negative staining transmission electron
microscopy. Representative negative stain images of the indicated virus particles harvested from the
supernatant of infected MDCK cells. Scale bars = 200 nm. Differences in particle appearance are
not due to morphological changes but to slight modifications of microscope settings and staining
conditions of the virus suspensions. Occasionally, filamentous and aberrant formed particles were
also observed in each virus preparation, the latter might be an artefact of ultracentrifugation [39].
However, although all effects are rather small (compared to the essential nature of the
cytoplasmic palmitoylation sites and adjacent hydrophobic residues), the repeated occurrence of
amino acid reversion suggests that conserved residues in the tail and in the TMD confer a growth
advantage (Figure 2). The most striking example is the repeated and rapid occurrence of an amino
acid reversion to serine if a conserved glycine in the TMD was exchanged to isoleucine, a typical
constituent of transmembrane domains. Since the other possible single nucleotide exchanges in
that codon would specify either a hydrophilic residue (asparagine) or hydrophobic amino acid
(isoleucine, leucine, phenylalanine, valine, threonine, methionine), the latter are typical constituents
of transmembrane regions, the repeated reversion to serine strongly suggests that a small amino acid
is preferred at that position. The transmembrane region of HA is likely to be α-helical [40] and when
the inner part of the TMD (541VLVVSLGAISFWMC554) is plotted as a helical wheel, G547 is located
together with other small amino acids (V543, S550) on the same side of the helix as the stearoylated
cysteine 554. One might speculate that these small residues are located on the outer surface of the
trimeric TMD where they might form a groove which binds stearate to align it with the TMD helix as
previously speculated [41]. Alternatively, glycine residues are often located at the interface between
6471
Viruses 2015, 7, 6458–6475
oligomeric transmembrane regions where they mediate helix-helix interactions [42]. In both cases the
substitution of the small glycine residue (amino acid volume of 70 Å3) by the large residue isoleucine
(volume of 170 Å3) might disrupt the assumed interaction and, therefore, a spontaneous reversion to
serine (volume of 100 Å3) confers a growth advantage.
However, our results are difficult to reconcile with the assumption that the cytoplasmic tail of HA
alone recruits M1 to the viral assembly site, at least if this is assumed to occur by hydrophilic binding
forces, such as salt bridges or hydrogen bonds. The hydrophobic patch ICI (563–565) at the C-terminal
end of the tail plus the second palmitoylation site in close proximity (561) likely anchors the tail to
the inner side of the plasma membrane (Figure 6). This assumption is based on the observation
that the exchange of the acylated cysteines by serine is lethal whereas their substitution by residues
with the propensity to insert into lipid bilayers allows virus rescue [15]. Likewise, substitution of
isoleucine 563 by the hydrophilic residue glutamine prevents virus rescue, while its exchange by
a long and hydrophobic leucine residue has only a minor effect. In addition, substitution of leucine
559 by a cysteine, which is stoichiometrically used as acylation site [22], reduces the virus growth
only slightly suggesting that this residue in the cytoplasmic tail also interacts with membranes.
In proximity to these acylated or hydrophobic residues is the conserved basic amino acid arginine
562, which has the capacity to interact with the head groups of negatively charged lipids, abundant
components at the inner leaflet of the plasma membrane [43]. Thus, if many amino acid side chains (or
attached fatty acids) of the cytoplasmic tail of HA are engaged in interactions with the lipid bilayer,
only four, N, G, S and Q, remain to specifically bind to M1 (Figure 6). However, exchange of two
of them, G 557 and Q 560 had very little influence on virus growth. This suggests that they do not
bind with high-affinity to M1 since one would assume that replacement of an amino acid making an
essential contact with M1 would result in a more drastically impairment of virus growth. However,
in our mutagenesis study, we concentrated on amino acids conserved between all HA subtypes, and
it might be that even non conserved residues might have a substantial impact on virus assembly
and budding.
Journal 2015, volume, page–page 
15 
, our results are difficult to reconcile wi  the assumption hat the cytoplasmic tail of 
HA alone recruits M1 to the viral assembly site, at lea t if this is assumed to occur by hydrophilic 
binding forces, such as salt bridges or hydrogen bon s. T e hydrop obic patch ICI (563–565) at the 
C-terminal end of the tail plus the sec nd palmi oylation site in close proximity (561) likely anchors 
 tail to the inner side of th  plasma membrane (Figure 6). This a sumpti  is based on the 
observation that the exchange of the acylated cysteines by serine is lethal whereas their substitution 
by residues with the propensity to insert into lipid bilayers allows virus rescu  [15]. Likewise, 
substitution of isoleucine 563 by the hydrophilic residue glu am ne p vents virus rescue, while its 
exchange by a long and hydrophobic leucine residue has o ly a minor effect. I  addition, 
substitution of l ucine 559 by a cyst ine, which is toichiometr cally used as acylation site [22], 
reduces the virus growth only lightly suggesting that this residue in he cytoplas ic tail also 
i te acts with membr nes. In proximity to these acylated or hydrophobic residues is the conserved 
basic amino cid arginine 562, which has e capacity to interact with the head roups of negatively 
harged lipids, abu dant compon nts at the inner l aflet of the plasma embrane [43]. Thus, if 
many amino acid ide c ains (or attached fatty acids) of the cytoplasmic tail of HA are engaged in 
interactions with the lipid bil yer, only four, N, G, S and Q, remain to specifically bind to M1 
(Figure 6). However, exchange of two of them, G 557 and Q 560 ad very little influence on virus 
growth. T is sugges s that they do not bind with high-affinity to M1 since one w uld assume that 
replacement of an amino aci  making n essential contact with M1 would result in a more 
drastically impairment of virus growth. H wever, in our mutagenesis study, we concentrated on 
amino acids conserved between all HA ubtypes, and it might be ha  even non conse ved residues 
might have a substantial impact on virus assembly and budding. 
 
Figure 6. Model of the cytoplasmic tail of HA. Amino acids, indicated in single letter code, which 
were exchanged in this study, are underlined. Essential amino acids, i.e., the non-conservative 
substitution of which prevented rescue of infectious virus particles, are in red. Fatty acids attached 
to CT and TMD cysteine residues are depicted by a black (palmitate) or purple (stearate) zigzag 
line. Hydrophobic or positively charged amino acids that probably interact with the acyl chains or 
head groups of (negatively charged) lipids are in purple.  
Nevertheless, there is clear evidence that HA of both Influenza A and B virus at least 
functionally interacts with M1 during budding [13,37]. M1, a hydrophobic protein that has the 
capacity to partially insert into lipid bilayers [44–46], might interact with residues located within the 
inner (and variable) part of the TMD of HA. This assumption might explain why expression of M1 
from WSN virus rescues the otherwise lethal deletion of acylation sites from HA of Udorn virus 
[13]. The two essential cytoplasmic palmitates might also stick to the hydrophobic surface of M1. 
Figure 6. Model of the cytoplasmic tail of HA. Amino acids, indicated in single letter code, which were
exchanged in this study, are underlined. Essential amino acids, i.e., the non-conservative substitution
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Nevertheless, there is clear evidence that HA of both Influenza A and B virus at least functionally
interacts with M1 during budding [13,37]. M1, a hydrophobic protein that has the capacity to partially
insert into lipid bilayers [44–46], might interact with residues located within the inner (and variable)
part of the TMD of HA. This assumption might explain why expression of M1 from WSN virus
rescues the otherwise lethal deletion of acylation sites from HA of Udorn virus [13]. The two essential
cytoplasmic palmitates might also stick to the hydrophobic surface of M1. Alternatively, HA and
M1 might not form protein interactions but promote virus budding indirectly, e.g., by changing the
fluidity of the plasma membrane to create a stable assembly site. In addition, the cytoplasmic tail
of NA, which is completely conserved through all subtypes, might recruit M1 to the viral assembly
site. This is consistent with a recent study using Cryo-EM concluding that expression of M1 and M2
together with either of the viral glycoproteins is the minimal requirement to assemble and release
virus-like particles [47] and also with the observation that the cytoplasmic tails of both HA and NA
control the shape of virus particles [21].
Supplementary Materials: The following are available online at http://www.mdpi.com/1999-4915/7/12/6458/
s1, Table S1: Sequence comparison of the C-terminal region of HA subtypes, Table S2: Consensus sequence of
the C-terminal part of HA subtypes.
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